Literature DB >> 9326227

Fib420, the novel fibrinogen subclass: newborn levels are higher than adult.

G Grieninger1, X Lu, Y Cao, Y Fu, B J Kudryk, D K Galanakis, K M Hertzberg.   

Abstract

Fib420 is a recently identified subclass of normal human fibrinogen in which two extended alpha chain isoforms (alphaE) replace the common alpha chains, yielding a molecule (ca. 420 kD) which is larger than the more abundant 340-kD form. Evidence for preservation of this subclass throughout vertebrate evolution suggests it performs some as yet unidentified vital function. A survey was undertaken to establish the range of plasma Fib420 levels in normal, healthy adults and in placental cord (fetal) blood. For measuring Fib420, a quantitative Western blot assay was developed using monoclonal antibody against the exon-VI encoded C-terminus of the molecule's unique alphaE chain. This alphaE chain signal was normalized to that of the beta chain, common to both fibrinogen forms. Analysis of plasma samples from the adult and newborn cohorts (n = 25 each; total fibrinogen ca. 2.6 mg/mL in both) revealed a statistically significant difference, with a mean level of 100 +/- 28 microg/mL in the neonate compared to 34 +/- 7 microg/mL in the adult. On average, 1 out of every 100 fibrinogen molecules in adult plasma belongs to the Fib420 subclass. Unlike in the newborn, adult Fib420 levels remained the same over a wide range of total plasma fibrinogen. The striking difference observed between these two cohorts suggests a changing developmental expression of the Fib420 subclass and a homeostatic control operating in later stages of life.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326227

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Crystal structure of a recombinant alphaEC domain from human fibrinogen-420.

Authors:  G Spraggon; D Applegate; S J Everse; J Z Zhang; L Veerapandian; C Redman; R F Doolittle; G Grieninger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

2.  Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia.

Authors:  Zhilian Hu; Kari I Lavik; Yang Liu; Andy H Vo; Catherine E Richter; Jorge Di Paola; Jordan A Shavit
Journal:  J Thromb Haemost       Date:  2019-02-25       Impact factor: 5.824

3.  A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen AαE in early hemostasis.

Authors:  Cristina Freire; Richard J Fish; Rui Vilar; Corinne Di Sanza; Steven J Grzegorski; Catherine E Richter; Jordan A Shavit; Marguerite Neerman-Arbez
Journal:  Blood Adv       Date:  2020-11-10

4.  Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.

Authors:  Arshi Naz; Arijit Biswas; Tehmina Nafees Khan; Anne Goodeve; Nisar Ahmed; Nazish Saqlain; Shariq Ahmed; Ikram Din Ujjan; Tahir S Shamsi; Johannes Oldenburg
Journal:  Thromb J       Date:  2017-09-12

Review 5.  Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective.

Authors:  Fanny Risser; Ivan Urosev; Joanan López-Morales; Yang Sun; Michael A Nash
Journal:  Biophys Rev       Date:  2022-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.